We create, build, and scale healthcare companies
We don't just fund companies. We build them. Origyn is a MedTech venture studio that transforms unmet clinical needs into scalable businesses. Our focus is the health of women, where innovation is long overdue.
View Portfolio →We don't just ask 'can we build it?' We ask 'should we build it?'
Origyn is a venture studio founded and led by experienced medtech operators. We originate, build and capitalize healthcare companies tackling the largest markets in women's health.
The structural under-investment in the health of women is a generational opportunity. We exist to close that gap.
For most of medicine's history, women have been treated as a smaller version of the male body — clinically, anatomically, financially. The data, the devices, and the dollars never quite caught up. This creates a tremendous untapped market opportunity.
Conditions affecting millions —
Billions in unrealized value
addressable women's-health market by 2040 if the historic capital and care gap is even partially closed.
of U.S. women experience at least one pelvic floor disorder. The number rises with age — and with how rarely we look for it.
of all births in the U.S. arrive preterm. The leading cause of neonatal mortality, and a market still without a definitive screening device.
couples globally face infertility. Diagnostic pathways remain expensive, invasive, and disproportionately costly to women.
of all cancers diagnosed in U.S. women are gynecologic — a category whose screening tools have changed remarkably little in decades.
From clinical insight to commercial impact
Listen to the room
We start in the operating room, the clinic, the lab. Our partners are the surgeons and scientists living the unmet need.
Pressure-test everything
From IP and prototype through regulatory strategy, we de-risk in-house before a company ever raises outside capital.
Capitalize and commercialize
We launch companies with strong founding teams and capital partners as well as stay on as an equity holder and board partner through exit.
Companies built to redefine the standard of care
Have an idea worth building?
We partner with clinicians, scientists, and operators who see the gap clearly enough to want to close it. If that sounds like you — let's talk.
Start a conversation →